tiprankstipranks
Trending News
More News >
Spyre Therapeutics, Inc (SYRE)
NASDAQ:SYRE
US Market

Spyre Therapeutics (SYRE) Technical Analysis

Compare
457 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Spyre Therapeutics, Inc’s (SYRE) Moving Averages Convergence Divergence (MACD) indicator is -0.07, suggesting Spyre Therapeutics, Inc is a Buy.
Spyre Therapeutics, Inc’s (SYRE) 20-Day exponential moving average is 15.71, while Spyre Therapeutics, Inc’s (SYRE) share price is $15.76, making it a Buy.
Spyre Therapeutics, Inc’s (SYRE) 50-Day exponential moving average is 15.81, while Spyre Therapeutics, Inc’s (SYRE) share price is $15.76, making it a Sell.

Spyre Therapeutics (SYRE) Pivot Points

Jul 07, 2025, 06:33 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
13.62
14.44
14.97
15.79
16.32
17.14
17.67
Fibonacci
14.44
14.96
15.27
15.79
16.31
16.62
17.14
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Spyre Therapeutics (SYRE) Moving Averages

Jul 07, 2025, 06:33 PM
Period
Simple
Exponential
MA5
15.39Buy
15.54Buy
MA10
15.38Buy
15.60Buy
MA20
16.18Sell
15.71Buy
MA50
15.33Buy
15.81Sell
MA100
16.50Sell
17.17Sell
MA200
22.04Sell
21.36Sell
Spyre Therapeutics, Inc’s (SYRE) 10-Day exponential moving average is 15.60, while Spyre Therapeutics, Inc’s (SYRE) share price is $15.76, making it a Buy.
Spyre Therapeutics, Inc’s (SYRE) 100-Day exponential moving average is 17.17, while Spyre Therapeutics, Inc’s (SYRE) share price is $15.76, making it a Sell.
Spyre Therapeutics, Inc’s (SYRE) stock price is $15.76 and Spyre Therapeutics, Inc’s (SYRE) 50-day simple moving average is 15.33, creating a Buy signal.
Spyre Therapeutics, Inc’s (SYRE) stock price is $15.76 and Spyre Therapeutics, Inc’s (SYRE) 100-day simple moving average is 16.50, creating a Sell signal.
Spyre Therapeutics, Inc’s (SYRE) stock price is $15.76 and Spyre Therapeutics, Inc’s (SYRE) 200-day simple moving average is 22.04, creating a Sell signal.

Spyre Therapeutics (SYRE) Technical Indicators

Jul 07, 2025, 06:33 PM
Name
Value
Implied Action
RSI (14)
50.55
Neutral
STOCH (9,6)
48.13
Neutral
STOCHRSI (14)
37.58
Neutral
MACD (12,26)
-0.07
Buy
ADX (14)
16.28
Buy
Williams %R
-55.15
Buy
CCI (14)
-23.04
Neutral
ATR (14)
1.20
-
Ultimate Oscillator
43.12
Neutral
ROC
-11.01
Sell
Spyre Therapeutics, Inc’s (SYRE) Relative Strength Index (RSI) is 50.55, creating a Neutral signal.
Spyre Therapeutics, Inc’s (SYRE) Trend Strength Indicator (ADX) is 16.28, creating a Buy signal.
Spyre Therapeutics, Inc’s (SYRE) Commodity Channel Index (CCI) is -23.04, creating a Neutral signal.
Spyre Therapeutics, Inc’s (SYRE) Price Rate of Change (ROC) is -11.01, creating a Sell signal.

FAQ

Is SYRE a Buy, Hold, or Sell?
Based on SYRE’s technical indicators, SYRE is a Buy.
    What is SYRE’s RSI (14)?
    SYRE’s RSI (14) is 50.55, which suggests SYRE is a Neutral.
      What is SYRE’s MACD?
      SYRE’s MACD is -0.07, which suggests SYRE is a Buy.
        What is SYRE’s 5-day moving average?
        SYRE’s 5-day moving average is 15.39, which suggests SYRE is a Buy.
          What is SYRE’s 20-day moving average?
          SYRE 20-day moving average is 16.18, which suggests SYRE is a Sell.
            What is SYRE’s 50-day moving average?
            SYRE’s 50-day moving average is 15.33, which suggests SYRE is a Buy.
              What is SYRE’s 200-day moving average?
              SYRE’s 200-day moving average is 22.04, which suggests SYRE is a Sell.
                What is SYRE’s Williams % R (14)?
                SYRE’s Williams % R (14) is -55.15, which suggests SYRE is a Buy.
                  What is SYRE’s CCI (14)?
                  SYRE’s CCI (14) is -23.04, which suggests SYRE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis